•
NC
NCNA
NuCana plc American Depositary Share
polygon--
Price Chart
Market Cap
13.53M
Volume
3.29K
52W High
$268.00
52W Low
$2.78
Open
$3.27
Prev Close
$3.25
Day Range
3.27 - 3.27
About NuCana plc American Depositary Share
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.
Latest News
NuCana Appoints Theresa Bruce as Chief Operating Officer
GlobeNewswire Inc.•Jan 6
NuCana Presents Latest Data Demonstrating Clinical Activity and Favorable Safety for NUC-7738 in Patients with PD-1-Resistant Melanoma
GlobeNewswire Inc.•Dec 10
NuCana Announces Grant of Composition-of-Matter Patent for NUC-7738 in China
GlobeNewswire Inc.•Nov 5
NuCana to Present Data on NUC-7738’s Synergy with PD-1 Inhibitors at the ESMO Congress 2025
GlobeNewswire Inc.•Sep 3
NuCana Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.•Aug 15
NuCana to Present at the Jefferies Global Healthcare Conference
GlobeNewswire Inc.•May 30
NuCana to Present at TD Cowen’s 5th Annual Oncology Innovation Summit
GlobeNewswire Inc.•May 21
NuCana Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire Inc.•May 16